News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
119 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17909)
Month
January (2488)
February (2603)
March (3229)
April (2950)
May (3962)
June (3500)
July (2854)
August (3142)
September (3205)
October (3540)
November (3386)
December (2332)
Day
2 (186)
3 (175)
4 (147)
5 (166)
6 (119)
9 (121)
10 (183)
11 (172)
12 (142)
13 (112)
14 (38)
15 (1)
16 (171)
17 (154)
18 (148)
19 (149)
20 (92)
21 (2)
23 (153)
24 (148)
25 (216)
26 (204)
27 (119)
28 (2)
29 (9)
30 (193)
31 (218)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
2
3
4
5
6
9
10
11
12
13
14
15
16
17
18
19
20
21
23
24
25
26
27
28
29
30
31
Policy
Sandoz Proposed Biosimilar Pegfilgrastim Accepted by EMA for Regulatory Review
Pegfilgrastim is a long-acting formulation of filgrastim and Sandoz is seeking approval for use of its biosimilar in the same indication as the reference medicine.
October 27, 2017
·
6 min read
Pharm Country
CRF Health’s TrialMax Touch Solution Selected for Landmark Global Oncology Study
The three year study marks CRF Health’s involvement in over 115 oncology studies which have realized the benefits of electronically collected eCOA data, and aims to better understand patients’ quality of life post-treatment.
October 27, 2017
·
2 min read
Drug Development
Sunovion Presents Data From Phase III Studies of Latuda (Lurasidone HCl) in Children and Adolescents With Bipolar Depression
The results showed that six weeks of treatment with LATUDA was associated with statistically significant and clinically meaningful improvement in a wide range of depressive symptoms compared to placebo.
October 27, 2017
·
17 min read
UBM Release: New Dedicated Biopharma Event Launches Alongside CPhI Worldwide 2018 in Madrid
The new event has been created after independent research identified a gap in the market for a new global exhibition and content platform that could establish premium-class, global leadership across the entire bio manufacturing value chain.
October 27, 2017
·
5 min read
Business
CytomX Therapeutics to Announce Third Quarter 2017 Financial Results
The company will not conduct a conference call in conjunction with this financial results press release.
October 27, 2017
·
1 min read
Business
Dyadic International to Announce Third Quarter 2017 Financial Results and Host Conference Call on Thursday November 9, 2017
A conference call will be held at 5:00 p.m. Eastern Time to discuss those results.
October 27, 2017
·
4 min read
Karolinska Development - Interim Report (January-September 2017) - Invitation To Conference Call And Webcast
The company will also host a conference call and an online presentation on October 31, at 2 pm CET.
October 27, 2017
·
1 min read
Genetown
Corindus to Feature CorPath GRX System at the Transcatheter Cardiovascular Therapeutics 2017 Conference
The symposium, chaired by Sunil V. Rao, M.D., FSCAI of Duke University Medical Center and featuring faculty from leading cardiovascular institutions, will focus on the benefits of radial access combined with robotic assistance for PCI.
October 27, 2017
·
5 min read
Business
BioInvent Expands The Development Program for BI-1206 With A New Clinical Trial
Comments from the CEO: “During the third quarter of 2017, BioInvent has initiated preparations for a clinical trial with BI-1206 in combination with rituximab to investigate its potential as a treatment of relapsing, aggressive forms of Non-Hodgkin Lymphoma and indolent lymphomas.”
October 27, 2017
·
1 min read
Previous
12 of 12